✦ LIBER ✦

The levodopa dose-sparing capacity of pergolide compared with that of bromocriptine in an open-label, crossover study

✍ Scribed by J. Boas; J. Worm-Petersen; E. Dupont; B. Mikkelsen; L Wermuth

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, multicentre clinical tria

✍ M. M. Pinter; A. W. F. Rutgers; E. Hebenstreit; on behalf of the the study cente 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 198 KB

Comparative Bioavailability of 2 Tablet

✍ Guillermo A. Keller; Paola Czerniuk; Roberto Bertuola; Juan G. Spatz; Aria R. As 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 438 KB

An Open-Label, Single-Dose, Crossover St

✍ Fatta B. Nahab; Loretta Wittevrongel; Dominic Ippolito; Camilo Toro; George J Gr 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 247 KB

An open-label, randomized, flexible-dose

✍ I. Eardley; P. Wright; R. MacDonagh; J. Hole; A. Edwards 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Relative bioavailability of tizanidine h

✍ Herbert R. Henney III; Anthony Fitzpatrick; Johnston Stewart; Jacob D. Runyan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 910 KB

Comparative pharmacokinetic evaluation o

✍ SeungHwan Lee; Yong-Ju Chung; Bo-Hyung Kim; Jun-Hwa Shim; Seo-Hyun Yoon; Sang-Go 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 125 KB